Hopkins researcher finds bone disease and growth defect may have common genetic basis

November 09, 2000

An examination of two rare, very different and hereditary bone disorders has revealed clues about the common genetic switches controlling normal bone development, according to new research guided by Johns Hopkins Children's Center endocrinologist Michael Levine, M.D.

In the November issue of the Journal of Bone and Mineral Research, Levine's group describes two girls diagnosed with both Albright's hereditary osteodystrophy (AHO) and progressive osseous heteroplasia (POH). They found that abnormal bone formation was more severe in the two girls than in patients with AHO alone and that the girls' symptoms were more typical of POH, implying that the developmental and biochemical pathways leading to each condition intersect at some point along the way.

Both girls had severely depressed levels of an important protein called Gs-alpha that helps cells adjust their internal energy use in accordance with the body's needs, suggesting that metabolic pathways using Gs-alpha are the collective culprit behind AHO and POH. How mutant changes in these pathways lead to the development of bone in soft tissues remains unknown, Levine says, but researchers now know where to look.

Levine's group studied red blood cells from two girls, ages 7 and 10, and analyzed the many proteins that swim inside or on the surface of cell membranes. Using antibodies to selectively hunt down Gs-alpha and bind to it, they compared the concentrations of Gs-alpha in the red blood cells with that of normal red blood cells. In both girls, red blood cells contained about half as much Gs-alpha as normal red blood cells.

A gene, GNAS1, provides the DNA blueprint for Gs-alpha, a protein that plays a critical role in making sure a cell can respond to its external environment. Part of an elegantly complex metabolic system called a signal transduction pathway, normal levels of Gs-alpha make sure that cells can respond to hormones by changing which genes are turned on and off, as well as how fast many proteins work.

Patients diagnosed with progressive osseous heteroplasia develop spontaneous bone fragments under the skin and deep inside their bodies. The fragments can be as large as rice grains and often cause acute pain by pressing against nearby nerve cells. The lesions caused by POH can be identified, leading to diagnosis soon after birth. Albright hereditary osteodystrophy is characterized by short stature, obesity, relatively short fingers and, often, endocrine problems. AHO is usually diagnosed during childhood. Although the actual incidence of AHO and POH in the population is unknown, Levine estimates one of every 100,000 individuals is affected by either of the disorders. The two diseases rarely occur together in a single person.
-end-
Researchers from the Shriners Hospital for Children in St. Louis, Mo., and the Washington University School of Medicine in St. Louis, Mo., the University of Pennsylvania School of Medicine in Philadelphia, and the Shriners Hospital in Salt Lake City, Utah, contributed to the report. Support for the research came from grants supplied by the Shriners Hospital for Children in St. Louis, The Clark and Mildred Cox Inherited Metabolic Bone Disease Research Fund, The International Fibrodysplasia Ossificans Progressiva Association, the Progressive Osseus Heteroplasia Association, the New Jersey Association of Student Councils, the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine, and the National Institutes of Health.

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at http://www.eurekalert.org, and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

Media Contact: David Bricker 410-223-1728
Email: dbricker@jhmi.edu

Johns Hopkins Medicine

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.